
By pursuing excellence in research, IBS has selected global leading scientists as directors of Centers. These directors are operating 31 Centers of which research proposals are evaluated superior in the IBS peer review process. The review is carried out by a Review Panel composed of independent and expert scientists from Korea and abroad. Directors choose the themes of their research and allocate funds accordingly. Generally, Centers operate projects with no fixed term for their duration as long as the quality of research is verified in evaluations. New Centers receive an initial evaluation five years after its launch, followed by three-year interval evaluations. IBS has been inviting top scientists from around the globe and providing them full support for their relocations. Young scientists also enjoy unique research opportunities to collaborate with world renowned scientists and to organize and operate their own research groups, broadening their professional expertise. IBS brings together outstanding talents throughout all career levels to grow and inspire each other through close collaborations.
我们正在追踪 Institute For Basic Science (IBS) 的市场扩张
最近 90 天内有 1 个信号。
Institute For Basic Science (IBS) 的国际扩张与竞争对手的对比情况
条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
Institute For Basic Science (IBS)你 | 0 | 0 | — | 0 | 0 |
当前没有招聘
注册以跟踪该公司,并在发生变化时第一时间获得提醒。
没有进行中的营销活动
注册以跟踪该公司,并在发生变化时第一时间获得提醒。
IBS研究人员开发了'CDr17',一种可选择性检测M1巨噬细胞的荧光分子,有望改善类风湿性关节炎等自身免疫疾病的诊断。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Institute For Basic Science (IBS) 的业务、市场和增长信号的快速解答。
